Mazdutide Outperforms Semaglutide in Type 2 Diabetes and Obesity: Results from the Phase 3 DREAMS-3 Trial
Previously Published on hcplive.com — Innovent Biologics has announced impressive results from the DREAMS-3 phase 3 clinical trial, demonstrating the…